Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5203126
Max Phase: Preclinical
Molecular Formula: C29H41N3O3
Molecular Weight: 479.67
Associated Items:
ID: ALA5203126
Max Phase: Preclinical
Molecular Formula: C29H41N3O3
Molecular Weight: 479.67
Associated Items:
Canonical SMILES: Cc1cc(N(C)C(=O)[C@H]2CC[C@H](Oc3cc(CO)ccc3C)CC2)ccc1CN1CCN[C@@H](C)C1
Standard InChI: InChI=1S/C29H41N3O3/c1-20-5-6-23(19-33)16-28(20)35-27-11-8-24(9-12-27)29(34)31(4)26-10-7-25(21(2)15-26)18-32-14-13-30-22(3)17-32/h5-7,10,15-16,22,24,27,30,33H,8-9,11-14,17-19H2,1-4H3/t22-,24-,27-/m0/s1
Standard InChI Key: HOYGTZVNGBHQOX-DPPGTGKWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 479.67 | Molecular Weight (Monoisotopic): 479.3148 | AlogP: 4.19 | #Rotatable Bonds: 7 |
Polar Surface Area: 65.04 | Molecular Species: BASE | HBA: 5 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.35 | CX LogP: 4.22 | CX LogD: 2.28 |
Aromatic Rings: 2 | Heavy Atoms: 35 | QED Weighted: 0.62 | Np Likeness Score: -0.79 |
1. Toda N, Shida T, Takano R, Katagiri T, Hirouchi M, Abe M, Soma K, Nakagami Y, Yamazaki M.. (2022) Discovery of DS-3801b, a non-macrolide GPR38 agonist with N-methylanilide structure., 59 [PMID:35051575] [10.1016/j.bmcl.2022.128554] |
Source(1):